Clinical trial-based cost-effectiveness analyses of antipsychotic use.
about
Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care.Paliperidone: the evidence of its therapeutic value in schizophrenia.Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs.The impact of comparative effectiveness research on health and health care spending.A retrospective observational study of the effectiveness of paliperidone palmitate on acute inpatient hospitalization ratesEconomic outcomes associated with atypical antipsychotics in bipolar disorder: a systematic review.Rethinking antipsychotic formulary policy.Hidden Empirical Research Ethics: A Review of Three Health Journals from 2005 through 2006.Principles of antipsychotic prescribing for policy makers, circa 2008. Translating knowledge to promote individualized treatment.Who are the new users of antipsychotic medications?Unmet treatment needs in schizophrenia patients: is asenapine a potential therapeutic option?The pharmacoeconomics of managing acute agitation in the emergency department: what do we know and how do we approach it?Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy.Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist.Persistence of racial disparities in prescription of first-generation antipsychotics in the USA.Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example.A clinician's guide to correct cost-effectiveness analysis: think incremental not average.
P2860
Q34116503-0B864B20-10FD-46AD-ACAB-713F57B2320FQ34449894-DAEEB2C6-BE2C-4210-BFF9-887E9FB6E3F1Q34541147-52D076CD-F14F-43A1-8539-55AB84AE8E29Q35622994-C68D00F5-E5C9-40EF-8310-8326DBC88498Q35688404-8DDE352B-806B-4850-BAEB-AAE77504603EQ36274272-87725BAC-0963-417B-A982-A8AE0FEC1525Q36883316-784C7D3F-4F18-47EE-B1D6-F0ECEAFCC5F8Q37184605-4AB5330E-C416-4BD6-9525-194E00D59EB4Q37310164-05664E26-3201-4E1C-B413-EEF9E7147875Q37337653-3007EBE4-F141-4195-BC1F-C6B338A9CD3BQ37896627-3E6A54D9-44F6-42EB-BD85-4C44D3308B59Q38062949-52DAC057-DCB8-41ED-BCEB-5C2468767F74Q38364288-DEC47FA4-A897-4774-8D3F-FEA12C4C6C83Q38668022-7D9F3115-9314-40F3-9B9D-B1F27AC94249Q40778551-20CB6A2F-F83C-4D6D-AEDB-26F2BD803516Q41449760-F31D1885-94E9-4291-BA68-5264F76E7A24Q51890823-7A06CDD8-758B-4FCB-8E77-C93D96249679
P2860
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
@ast
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
@en
type
label
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
@ast
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
@en
prefLabel
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
@ast
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
@en
P2093
P1476
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
@en
P2093
Daniel Polsky
Henry A Glick
Jalpa A Doshi
Mark S Bauer
P304
P356
10.1176/AJP.2006.163.12.2047
P407
P577
2006-12-01T00:00:00Z